Ultrasound Department, First Affiliated Hospital of Chinese PLA General Hospital , Beijing .
Int J Hyperthermia. 2014 Feb;30(1):11-8. doi: 10.3109/02656736.2013.853107. Epub 2013 Nov 28.
This study explores the agreement between ablated uterine myoma volumes obtained from contrast-enhanced sonography and enhanced magnetic resonance imaging (MRI) after microwave ablation therapy.
Twenty uterine myomas in 18 patients (average size: 5.56 ± 1.26 cm) were successfully treated by microwave ablation. Contrast-enhanced sonography and enhanced MRI were performed within 7 days after the treatment. The ablation range of uterine myomas was observed and the ablation volume was calculated. By using the intraclass correlation coefficient (ICC) and Bland-Altman regression analysis, the agreement between ablated uterine myoma volumes obtained from contrast-enhanced sonography and enhanced MRI after microwave ablation therapy was analysed.
The ablated volume ranged from 13.66 to 135.27 cm(3) after ablation, and the mean volume was 66.59 ± 35.71 cm(3) by using contrast-enhanced sonography. Respectively, the ablated volume ranged from 10.88 to 137.83 cm(3), and the mean volume was 66.81 ± 35.45 cm(3) by using enhanced MRI. The limits of agreement between the two methods were (-10.83 cm(3), 8.39 cm(3)), ICC was 0.991 (F = 209.61, P < 0.05), and 95% confidence interval is (0.976, 0.996). The results revealed a good agreement between the two examination methods of contrast-enhanced sonography and enhanced MRI.
Contrast-enhanced sonography and enhanced MRI can be used interchangeably in observing the ablation range of uterine myomas treated with microwave ablation. Contrast-enhanced sonography can be used as a preferred non-invasive examination and for follow-up. Meanwhile, enhanced MRI can be used to comprehensively determine the relationships among uterine myomas, the entire uterus, and surrounding tissues.
本研究探讨了微波消融治疗后增强超声与增强 MRI 测量消融后子宫肌瘤体积的一致性。
对 18 例 20 个子宫肌瘤患者(平均大小:5.56 ± 1.26 cm)进行微波消融治疗。治疗后 7 天内行增强超声和增强 MRI 检查。观察子宫肌瘤消融范围,计算消融体积。采用组内相关系数(ICC)和 Bland-Altman 回归分析评估微波消融治疗后增强超声与增强 MRI 测量消融后子宫肌瘤体积的一致性。
消融后肌瘤体积范围为 13.66 ~ 135.27 cm³,增强超声测量平均体积为 66.59 ± 35.71 cm³。分别用增强 MRI 测量体积范围为 10.88 ~ 137.83 cm³,平均体积为 66.81 ± 35.45 cm³。两种方法测量结果的一致性较好,其一致性界限为(-10.83 cm³,8.39 cm³),ICC 为 0.991(F = 209.61,P <0.05),95%置信区间为(0.976,0.996)。
增强超声与增强 MRI 可在观察微波消融治疗后子宫肌瘤消融范围时相互替代。增强超声可作为首选的无创检查和随访方法,而增强 MRI 可用于全面评估子宫肌瘤、整个子宫及周围组织之间的关系。